Johnson & Johnson Settles Opioid Claims In Texas For $291.8 Million

3 months ago 51

An introduction  motion   to the Johnson & Johnson field  shows their logo successful  Irvine, Calif., connected  Aug. 28, 2019. (Mark Ralston/AFP via Getty Images)

An introduction motion to the Johnson & Johnson field shows their logo successful Irvine, Calif., connected Aug. 28, 2019. (Mark Ralston/AFP via Getty Images)

Johnson & Johnson and its U.S.-based Janssen Pharmaceutical Companies have reached a $291.8 cardinal colony with the Texas authorities authorities that resolves its opioid-related claims made against the companies.

What Happened

Johnson & Johnson volition wage its colony sum into the Qualified Settlement Fund, which represents Texas’s allocation of the Global Prescription Opioid Litigation Settlement Agreement announced connected July 23.

The colony is related to the selling and promotion of the companies’ opioids Duragesic, Nucynta, and Nucynta ER. In a property statement, Johnson & Johnson said it nary longer sells medicine opioids and stressed that its 3 discontinued products “accounted for little than 1 percent of full opioid prescriptions successful Texas and the U.S. since launch.”

Why It Matters

Johnson & Johnson was accused of downplaying the addictive properties of its opioid products and aggressively selling them to physicians and patients. The U.S. Centers for Disease Control and Prevention estimated that much than 500,000 died from the opioid situation since 1999.

The Texas colony doesn’t necessitate the institution to marque an admittance of liability oregon wrongdoing.

Texas Attorney General Ken Paxton praised the settlement, declaring it represents “the adjacent measurement to bring much-needed backing for Texans who person fallen unfortunate to the irresponsible and deceptive selling practices from opioid manufacturers that spurred this epidemic.”

By Phil Hall

© 2021 The Epoch Times. The Epoch Times does not supply concern advice. All rights reserved.

Benzinga

Follow